New York State Common Retirement Fund’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.2K Hold
9,598
﹤0.01% 3040
2025
Q4
$49.7K Hold
9,598
﹤0.01% 2910
2025
Q3
$50.1K Hold
9,598
﹤0.01% 2951
2025
Q2
$36.8K Hold
9,598
﹤0.01% 3020
2025
Q1
$55.2K Hold
9,598
﹤0.01% 2738
2024
Q4
$47.9K Hold
9,598
﹤0.01% 2865
2024
Q3
$51.7K Sell
9,598
-9,000
-48% -$42.8K ﹤0.01% 2855
2024
Q2
$61.6K Hold
18,598
﹤0.01% 3040
2024
Q1
$60.8K Hold
18,598
﹤0.01% 2923
2023
Q4
$65.3K Sell
18,598
-86
-0.5% -$265 ﹤0.01% 2916
2023
Q3
$125K Buy
18,684
+484
+3% +$3.59K ﹤0.01% 2622
2023
Q2
$153K Buy
+18,200
New +$179K ﹤0.01% 2618
2022
Q3
Sell
-370
Closed -$1K 3262
2022
Q2
$1K Sell
370
-31,833
-99% -$109K ﹤0.01% 3310
2022
Q1
$143K Hold
32,203
﹤0.01% 2935
2021
Q4
$129K Sell
32,203
-129
-0.4% -$984 ﹤0.01% 3013
2021
Q3
$284K Sell
32,332
-9,168
-22% -$84.1K ﹤0.01% 2748
2021
Q2
$470K Buy
+41,500
New +$499K ﹤0.01% 2622
2020
Q2
Sell
-17,600
Closed -$43K 3214
2020
Q1
$43K Hold
17,600
﹤0.01% 3008
2019
Q4
$102K Hold
17,600
﹤0.01% 3001
2019
Q3
$93K Hold
17,600
﹤0.01% 3048
2019
Q2
$106K Hold
17,600
﹤0.01% 3076
2019
Q1
$159K Hold
17,600
﹤0.01% 2810
2018
Q4
$146K Hold
17,600
﹤0.01% 2835
2018
Q3
$243K Hold
17,600
﹤0.01% 2741
2018
Q2
$140K Buy
+17,600
New +$140K ﹤0.01% 3014

Other funds holding ALDX

New York State Common Retirement Fund's ALDX Position: Q1 2026 in Review

New York State Common Retirement Fund held its Aldeyra Therapeutics (ALDX) position steady in Q1 2026 at 9,598 shares worth $16.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

New York State Common Retirement Fund first reported a position in ALDX in Q2 2018 and has held it in 25 quarters since. The position peaked at $470K in Q2 2021. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • New York State Common Retirement Fund held 9,598 shares of Aldeyra Therapeutics worth $16.2K as of Q1 2026.
  • New York State Common Retirement Fund left its Aldeyra Therapeutics share count unchanged in Q1 2026.
  • Aldeyra Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #3040 holding.
  • New York State Common Retirement Fund first reported a position in Aldeyra Therapeutics in Q2 2018 and has held it in 25 quarters since.
  • New York State Common Retirement Fund's Aldeyra Therapeutics position peaked at $470K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.